← Leaderboards
Paul W Hruz
Washington University
$5,147,101
Attributed
$5,147,101
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $708.6K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,147,101 · 4
By mechanism
R01$4,185,945 · 2
K08$541,781 · 1
R21$419,375 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Mike M Mueckler$8,121,791
- Garland Ross Marshall$5,436,080
- Dominic N Reeds$11,620,890
- Marc S Levin$3,182,225
- Stephen Isaac Stone$644,717
Others in their field
Top investigators on “Glucose Transporter”
- Barbara B Kahn · Beth Israel Deaconess Medical Center$17,598,419
- Suzanne Craft · Wake Forest University Health Sciences$16,376,853
- Sherin U. Devaskar · University Of California Los Angeles$12,736,494
- Dan M Cooper · University Of California San Diego$12,414,992
- Ralph A Defronzo · University Of Texas Hlth Sci Ctr San Ant$12,360,716
- Timothy E McGraw · Weill Medical College Of Cornell Univ$12,240,393
Research focus
Glucose TransporterDiabetes MellitusXenopus OocytePharmaceutical PreparationsGlucose TransportUptakeDeoxyglucoseInsulin ResistanceNucleosidesAnimalsMolecularIndinavirMitochondriaMetabolicGlut4 GeneHeartMorbidity - Disease RateBinding SitesChronicAtazanavirCardiacGlucose UptakeAcuteHiv Protease Inhibitors
Grant awards (21)
SELECTIVE INHIBITION OF THE P. FALCIPARUM GLUCOSE TRANSPORTER PFHT$190,625
R21 · FY2019 · AI · contact PI
SELECTIVE INHIBITION OF THE P. FALCIPARUM GLUCOSE TRANSPORTER PFHT$228,750
R21 · FY2018 · AI · contact PI
DIRECT EFFECTS OF ANTIRETROVIRAL THERAPY ON CARDIAC ENERGY HOMEOSTASIS$361,760
R01 · FY2013 · HL · contact PI
DIRECT EFFECTS OF ANTIRETROVIRAL THERAPY ON CARDIAC ENERGY HOMEOSTASIS$380,000
R01 · FY2012 · HL · contact PI
DIRECT EFFECTS OF ANTIRETROVIRAL THERAPY ON CARDIAC ENERGY HOMEOSTASIS$380,000
R01 · FY2011 · HL · contact PI
DIRECT EFFECTS OF ANTIRETROVIRAL THERAPY ON CARDIAC ENERGY HOMEOSTASIS$387,500
R01 · FY2010 · HL · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$294,941
R01 · FY2010 · DK · contact PI
DIRECT EFFECTS OF ANTIRETROVIRAL THERAPY ON CARDIAC ENERGY HOMEOSTASIS$372,500
R01 · FY2009 · HL · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$297,920
R01 · FY2009 · DK · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$38,195
R01 · FY2009 · DK · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$297,920
R01 · FY2008 · DK · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$304,417
R01 · FY2007 · DK · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$262,952
R01 · FY2006 · DK · contact PI
Mechanisms for Altered Glucose Homeostasis During HAART$269,280
R01 · FY2005 · DK
Mechanism of GLUT4 Inhibition by HIV Protease Inhibitor$113,210
K08 · FY2005 · AI
Mechanisms for Altered Glucose Homeostasis During HAART$269,280
R01 · FY2004 · DK
Mechanism of GLUT4 Inhibition by HIV Protease Inhibitor$113,210
K08 · FY2004 · AI
Mechanisms for Altered Glucose Homeostasis During HAART$269,280
R01 · FY2003 · DK
Mechanism of GLUT4 Inhibition by HIV Protease Inhibitor$113,210
K08 · FY2003 · AI
Mechanism of GLUT4 Inhibition by HIV Protease Inhibitor$102,410
K08 · FY2002 · AI
Mechanism of GLUT4 Inhibition by HIV Protease Inhibitor$99,741
K08 · FY2001 · AI